Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Colorectal Neoplasms

  Free Subscription


09.03.2020

6 Anticancer Res
1 Br J Cancer
1 Cancer Lett
1 Cancer Res
1 Dis Colon Rectum
1 Eur J Cancer
1 Eur J Surg Oncol
1 Gastroenterology
1 Gut
3 Int J Colorectal Dis
1 Int J Oncol
2 Oncogene
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. KOJIMA T, Hino H, Shiomi A, Kagawa H, et al
    Surgical Outcomes of Laparoscopic and Open D3 Dissection for Clinical Stage II/III Descending Colon Cancer.
    Anticancer Res. 2020;40:1731-1737.
    PubMed     Text format     Abstract available

  2. HUNG YC, Chang WS, Chou AK, Pei JS, et al
    Association of Adiponectin Genotypes With Colorectal Cancer Susceptibility in Taiwan.
    Anticancer Res. 2020;40:1297-1306.
    PubMed     Text format     Abstract available

  3. SARHADI V, Lahti L, Saberi F, Youssef O, et al
    Gut Microbiota and Host Gene Mutations in Colorectal Cancer Patients and Controls of Iranian and Finnish Origin.
    Anticancer Res. 2020;40:1325-1334.
    PubMed     Text format     Abstract available

  4. KIM HJ, Han YS, Lee JH, Lee SH, et al
    Casein Kinase 2alpha Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress.
    Anticancer Res. 2020;40:1419-1426.
    PubMed     Text format     Abstract available

  5. KIMURA M, Usami E, Teramachi H, Yoshimura T, et al
    Risk Benefit of FOLFIRI Plus Ramucirumab as Third-line and Later-line Treatment of Metastatic Colorectal Cancer.
    Anticancer Res. 2020;40:1605-1611.
    PubMed     Text format     Abstract available

  6. WANG L, Hirano Y, Heng G, Ishii T, et al
    Mucinous Adenocarcinoma as a High-risk Factor in Stage II Colorectal Cancer: A Propensity Score-matched Study from Japan.
    Anticancer Res. 2020;40:1651-1659.
    PubMed     Text format     Abstract available


    Br J Cancer

  7. BARISCIANO G, Colangelo T, Rosato V, Muccillo L, et al
    miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer.
    Br J Cancer. 2020 Mar 5. pii: 10.1038/s41416-020-0773.
    PubMed     Text format     Abstract available


    Cancer Lett

  8. FAN M, Ma X, Wang F, Zhou Z, et al
    MicroRNA-30b-5p functions as a metastasis suppressor in colorectal cancer by targeting Rap1b.
    Cancer Lett. 2020 Feb 26. pii: S0304-3835(20)30084.
    PubMed     Text format     Abstract available


    Cancer Res

  9. TIAN J, Lou J, Cai Y, Rao M, et al
    Risk SNP-mediated enhancer-promoter interaction drives colorectal cancer through both FADS2 and AP002754.2.
    Cancer Res. 2020 Mar 3. pii: 0008-5472.CAN-19-2389.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  10. YOU JF, Hsu YJ, Chern YJ, Hung HY, et al
    Association of a Preoperative Leisure Time Physical Activity With Short- and Long-term Outcomes of Patients Undergoing Curative Resection for Stage I-III Colorectal Cancer: A Propensity Score Matching Analysis.
    Dis Colon Rectum. 2020 Feb 27. doi: 10.1097/DCR.0000000000001651.
    PubMed     Text format     Abstract available


    Eur J Cancer

  11. LUQUE-FERNANDEZ MA, Goncalves K, Salamanca-Fernandez E, Redondo-Sanchez D, et al
    Multimorbidity and short-term overall mortality among colorectal cancer patients in Spain: A population-based cohort study.
    Eur J Cancer. 2020;129:4-14.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  12. FOPPA C, Ng SC, Montorsi M, Spinelli A, et al
    Anastomotic leak in colorectal cancer patients: New insights and perspectives.
    Eur J Surg Oncol. 2020 Feb 24. pii: S0748-7983(20)30129.
    PubMed     Text format     Abstract available


    Gastroenterology

  13. KALTENBACH T, Anderson JC, Burke CA, Dominitz JA, et al
    Endoscopic Removal of Colorectal Lesions-Recommendations by the US Multi-Society Task Force on Colorectal Cancer.
    Gastroenterology. 2020 Feb 10. pii: S0016-5085(19)41948.
    PubMed     Text format    


    Gut

  14. WAN QY, Zhao R, Wang Y, Wu Y, et al
    Antibiotic use and risk of colorectal cancer: a meta-analysis of 412 450 participants.
    Gut. 2020 Feb 28. pii: gutjnl-2020-320826. doi: 10.1136/gutjnl-2020-320826.
    PubMed     Text format    


    Int J Colorectal Dis

  15. KIM S, Huh J, Lee WY, Yun SH, et al
    Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence.
    Int J Colorectal Dis. 2020 Feb 28. pii: 10.1007/s00384-020-03548.
    PubMed     Text format     Abstract available

  16. NG KS, West NP, Scott N, Holzgang M, et al
    What factors determine specimen quality in colon cancer surgery? A cohort study.
    Int J Colorectal Dis. 2020 Feb 28. pii: 10.1007/s00384-020-03541.
    PubMed     Text format     Abstract available

  17. YAGHOUBI A, Khazaei M, Avan A, Hasanian SM, et al
    The bacterial instrument as a promising therapy for colon cancer.
    Int J Colorectal Dis. 2020 Mar 4. pii: 10.1007/s00384-020-03535.
    PubMed     Text format     Abstract available


    Int J Oncol

  18. KIM B, Seo JH, Lee KY, Park B, et al
    Icariin sensitizes human colon cancer cells to TRAILinduced apoptosis via ERKmediated upregulation of death receptors.
    Int J Oncol. 2020;56:821-834.
    PubMed     Text format     Abstract available


    Oncogene

  19. HE Z, Thorrez L, Siegfried G, Meulemans S, et al
    The proprotein convertase furin is a pro-oncogenic driver in KRAS and BRAF driven colorectal cancer.
    Oncogene. 2020 Mar 6. pii: 10.1038/s41388-020-1238.
    PubMed     Text format     Abstract available

  20. DU F, Li X, Feng W, Qiao C, et al
    SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET.
    Oncogene. 2020 Feb 28. pii: 10.1038/s41388-020-1233.
    PubMed     Text format     Abstract available


    PLoS One

  21. CLARKE SJ, Burge M, Feeney K, Gibbs P, et al
    The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab: A translational study [ASCENT].
    PLoS One. 2020;15:e0229900.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: